CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
nasal intermittent positive pressure ventilationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00821119
NCT00821119N/ACompleted
CompareCT.gov

A Randomized Controlled Trial of Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Pressure as a Primary Mode for Respiratory Distress Syndrome in Preterm Infants

Instituto Materno Infantil Prof. Fernando Figueira·interventional·Posted Jan 13, 2009·Updated Mar 12, 2013

In Brief

A clinical study evaluating nasal intermittent positive pressure ventilation for Prematurity and Respiratory Distress Syndrome. Completed, enrolled 200 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the hypothesis that nasal intermittent positive pressure(NIPP), used as a primary mode of ventilation in preterm infants with RDS, will decrease the need for conventional endotracheal ventilation when compared to nasal continuous positive airway pressure.(NCPAP)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrematurity, Respiratory Distress Syndrome
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 13, 2009
Enrollment StartAug 1, 2007
Primary CompletionJul 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.5 years ago

Interventions

nasal intermittent positive pressure ventilationdevice

Nasal intermittent positive airway pressure will be compared are the nasal continuous positive pressure as an initial ventilatory mode in preterm infants with respiratory distress syndrome